Purpose. The objective of this study was to evaluate key motif requirements of human calcitonin (hCT)-derived peptides for the permeation through the plasma membrane of MDCK monolayers, as epithelial model. Methods. Truncated and sequence-modified fluorescent-labeled hCT-derived peptides were synthesized through Fmoc chemistry. Peptide uptake by confluent MDCK was observed by confocal laser scanning microscopy. The cytotoxic effect of the peptides on cellular integrity was followed by LDH release. For direct comparison we covered the cellular uptake of established cell penetrating peptides, Tat(47-57) and penetratin(43-58). Results. Truncated sequences of hCT, from hCT(9-32) to hCT(18-32), penetrated the plasma membrane and demonstrated a sectoral, punctuated cytoplasmic distribution. The uptake process appeared to be temperature-, time-and concentration-dependent. Amino acid modifications of hCT(18-32) indicated that both the proline in position 23 and the positive charge of lysine in position 18 are crucial for peptide uptake. The reverse sequence hCT(32-18) did not penetrate the membrane, indicating the importance of sequence orientation. Tat(47-57) and penetratin(43-58) showed a similar punctuated cytoplasmic distribution in MDCK and HeLa cell lines. No relevant toxicity was observed. Conclusions. Selected hCT-derived peptides have cell penetrating properties. The uptake mechanism seems to involve an endocytic pathway.
INTRODUCTION
The therapeutic potential of peptide-, protein-, and nucleic acid-based drugs is frequently compromised by their limited ability to cross the plasma membrane resulting in poor cellular access (1, 2) . Conjugation of such therapeutic agents to cell penetrating peptides (CPPs) has been suggested to improve their bioavailability. Several examples of CPPs have been described so far, such as 1) HIV-1 Tat-derived peptides (3) (4) (5) , 2) the third helix of the homeodomain of Antennapedia, i.e., penetratin [e.g. Antp(43-58)] (6,3) the herpes simplex virus VP22 protein (7, 8, 4) polyarginines (9, 10) . CPPs have been shown to cross cellular membranes and to deliver conjugated (or fused) biopharmaceuticals, such as peptide nucleic acids (PNAs) (11) , antisense oligonucleotides (12) , full-length proteins (4, 13) , or nanoparticles (14) and liposomes (15) into cells. The exact mechanisms underlying the translocation of CPP across the cellular membrane is still poorly understood. However, several similarities in translocation mechanism were found: the internalization of these peptides was neither significantly inhibited by low temperature, depletion of cellular ATP pool, nor inhibitors of endocytosis (3, 6, 10, 16) . Therefore, translocation was concluded to result from a direct transfer through the lipid bilayer of the cell membranes (3, 6) . Recently, however, the mechanisms of protein/peptide translocation have been re-evaluated and the involvement of endocytosis in cellular internalization of both CPPs and CPPs conjugated to PNAs has been suggested (17, 18) .
In the present study, we report on a new group of peptide sequences derived from the C-terminal domain of human calcitonin (hCT) with ability to translocate the plasma membrane of Madin-Darby canine kidney cell line (MDCK) monolayers, a meaningful cellular model for columnar-type epithelia (19, 20) . Our hCT-derived CPP carry a relatively low positive charge in contrast to other CPPs, which are highly positively charged (arginine-or lysine-rich) at physiologic pH (3, 10, 21) . A previous study demonstrated that the C-terminal fragment of hCT featuring residues 9 to 32, that is, hCT , as well as human calcitonin itself are internalized in vitro into bovine nasal epithelium (22) . Moreover, we previously showed that the green fluorescent protein conjugate GFPhCT(9-32) was also translocated into bovine nasal epithelium (23) . To further investigate the underlying principles of peptide uptake we analyzed, by confocal laser scanning microscopy (CLSM), key sequence requirements for translocation by generating a series of peptides by both truncations and sequence variations of hCT . The present work reveals that the minimally required hCT sequence that could be internalized in MDCK was hCT (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) . For reference, the investigated hCT peptides were compared with Tat(47-57) and penetratin(43-58) using cellular uptake assays in both MDCK and HeLa cells. Once translocated into the cells all the tested peptides demonstrated a punctuated cytoplasmic distribution, suggesting the involvement of endocytosis.
MATERIALS AND METHODS

Materials
MDCK (low resistance, type II) was a gift from the Biopharmacy group, ETH (Zurich, Switzerland; Ref. 20) . Cervical carcinoma cells, HeLa, were obtained from American Type Culture Collection (Rockville, MD, USA). Cell culture media, L-glutamine, penicillin, streptomycin, and phosphatebuffered saline without calcium and magnesium were from Invitrogen Corporation (Carlsbard, CA, USA). Fetal calf serum (FCS) was purchased from Winiger AG (Wohlen, Switzerland) and 5(6)-carboxyfluorescein from Fluka (Buchs, Switzerland). Hoechst 33342, LIVE/DEAD Viability/Cyto-toxicity kit assay and 5(6)-carboxytetramethylrhodamin (TAMRA) were purchased from Molecular Probes (Eugene, OR, USA). Human calcitonin (hCT) was a gift from H. Rink from Novartis (Basel, Switzerland). Human calcitonin generelated peptide (hCGRP) and human amylin (hAmylin) were purchased from Bachem (Bubendorf, Switzerland), and human adrenomedullin (hADM) from Peptide Institute in Osaka, Japan. Forskolin was from CalbioChem (San Diego, CA, USA). Tetramethyl rhodamine isothiocyanate (TRITC) dextran, lactate dehydrogenase (LDH) kits, and all other chemicals were commercially available. Cell culture inserts (polyethylene terephthalate, 4.2-cm 2 growth area, 0.4-m pore size, 1.6 × 10 6 pores/cm 2 ) and companion plates were purchased from Falcon (Franklin Lakes, NJ, USA). Glass chamber slides were obtained from Nunc (Roskilde, Denmark). Twelve-and 24-well plates were obtained from TPP (Trasadingen, Switzerland). The used UV spectrophotometer was a Varian Cary 50. The transepithelial electrical resistance of cell monolayers grown on inserts was measured using the Millicell-ERS system from Millipore (Billerica, MA, USA).
Methods
Synthesis of hCT Fragments, Labeling, and Identification
Linear hCT fragments were synthesized according to Rist et al. (24) using Rink amide resin to obtain C-terminal amides. All fragments were labeled at the N-terminus with 5(6)-carboxyfluorescein or with TAMRA, whereas the peptide was still bound to the resin with fully protected side chains (25) . Coupling was performed using an 8-fold excess of TAMRA or a 10-fold excess of 5(6)-carboxyfluorescein, diisopropylcarbodiimide, and 1-hydroxybenzotriazole. The overall coupling time was 30 min for 5(6)-carboxyfluorescein and 45 min for TAMRA. The 5(6)-carboxyfluorescein labeled peptides were cleaved with TFA/thioanisole/thiocresol (90:5: 5, v/v/v) within 3 h at room temperature, precipitated from cold diethyl ether, and collected by centrifugation. The crude peptides were dissolved in methanol/piperidine (9:1, v/v) and shaken for 1 h to remove excess of carboxyfluorescein. For TAMRA-labeled peptide, the excess dye was removed by extensive washing with N,N-dimethylformamide, dichloromethane, ethanol and diethylether, whereas the peptide was still attached to the resin. The TAMRA-labeled peptide was then cleaved and precipitated from cold diethyl ether and collected by centrifugation. All the peptides were subsequently lyophilized.
The following sequences were synthesized (Table I) . Nterminally truncated fragments: Starting from the C-terminal fragment hCT(9-32), we synthesized further peptides with various truncations, down to a total length of 9 amino acids, hCT (24) (25) (26) (27) (28) (29) (30) (31) (32) . C-terminally truncated fragment: hCT (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) . Amino acid replacements: Single amino acid replacements were performed in position 17, 18, 19, and 23 (see Table I for details). Extended sequences: For elongation of the C-terminal segment, we added two alanines to the C-terminus of hCT (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) . Reverse sequence: hCT , the reverse amino acid sequence of hCT (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) . Random sequence: A peptide sequence containing the 24 amino acids of hCT in a random position was synthesized as a negative control.
Peptides were purified by preparative high-performance liquid chromatography (HPLC) and their purity confirmed by HPLC analysis using a LiChrospher 100 RP-18 column with a flow rate of 1 ml/min using an acetonitrile:water (containing 0.1% TFA) gradient. Fluorescence was detected at 517 nm and UV at 220 nm. The molecular weight was verified by mass spectrometry (Finnigan Mat SSQ 710/ Waters 600-MS).
Synthesis of Tat(47-57) and Penetratin(43-58), Labeling, and Identification
Synthesis of Tat(47-57) and penetratin(43-58) (see Table  I ) were conducted by solid phase on an Applied Biosystems 433A peptide synthesizer following the Fmoc chemistry protocol. Two glycines were added, one at the N-terminal and one at the C-terminal end of the Tat(47-57) peptide to provide links for fluorochrome binding. In the case of penetratin(43-58), the C-terminal end was amidated to improve its stability. The peptides were labeled at the N-terminus with a 3-fold excess of 5(6)-carboxyfluorescein while still bound to the resin with fully protected side chains. The overall coupling time was 3 h followed by washing steps with N,N-dimethylformamide. The peptides were cleaved with TFA/water/triisopropylsilane/ethandithiol (92.5:2.5:2.5:2.5, v/v/v/v) within 2 h at room temperature, precipitated from tert-butylmethylether, collected by centrifugation, and lyophilized.
Peptides were purified by preparative HPLC and their purity confirmed by HPLC analysis using an EC 250/4 Nucleosil 300-5 C18 with a flow rate of 1 ml/min. A linear gradient starting at 90% solvent A (water:TFA, 99.9:0.1, v/v) and 10% solvent B (acetonitrile:TFA, 99.915:0.075, v/v) to 100% solvent B over 50 min. UV detection was set at 222 nm. The molecular weights were verified by mass spectrometry (Perkin-Elmer Sciex API III Quadrupol Biomolecular Mass Analyzer).
Cell Culture
MDCK cells were grown under standard conditions in minimum essential medium with Earl's salts containing 10% heat-inactivated FCS, 1% L-glutamine and 1% penicillin/ streptomycin (20) . HeLa cells were cultured as exponentially growing subconfluent monolayers on 25-cm 2 culture flasks in Dulbecco's modified eagle medium (high glucose) supplemented with 10% heat-inactivated FCS and 1% penicillin/ streptomycin.
CLSM
Exponentially growing MDCK and HeLa cells were seeded onto either four-well glass chamber slides or cells culture inserts, cultured 2 or 3 days for proliferating cells and 10 days for confluent cells. MDCK cells were seeded at a constant density of 2 × 10 4 cells/cm 2 and HeLa cells at 10 5 cells/ cm 2 . For confluent cells, medium was changed twice a week until confluent monolayers formed. For uptake experiments, cells were first incubated in serum free medium for 30 min. The medium was then discarded and the cells further incubated in serum-free medium containing fluorescence-labeled peptides or unconjugated fluorophore at the appropriate concentration. Simultaneously, nuclei were stained with 1 g/ml Hoechst 33342. When appropriate, endosomes were stained with TRITC-dextran. The study was conducted at 37°C or 4°C with horizontal mechanical shaking (150 rpm). Subsequently, cells were rinsed three times with serum-free me- dium and mounted with or without fixation. Fixation was performed at room temperature for 30 min in 3% (v/v) formaldehyde before being rinsed with phosphate-buffered saline. The cells were then scanned using a Zeiss CLSM 410 inverted microscope (20) and 3D multichannel image processing was performed using the IMARIS software.
Endosome Staining
MDCK proliferating cells growing on four-well glass chamber slides were incubated with 4 mg/ml TRITC-dextran for 45 min to stain endosomes (26) . Simultaneously, cells were incubated with 40 M of hCT-derived peptide. Before CLSM observations, cells were fixed.
LIVE/DEAD Viability/Cytotoxicity Assay
MDCK cells were incubated at 4°C for 45 min with cold serum-free medium. Thereafter, serum-free medium was removed and replaced by serum-free medium (37°C) containing a mixture of 3 M calcein AM (green stain of cytoplasm of enzymatically active viable cells, approx. 530 nm), and 6 M ethidium homodimer (passage of damaged cells membranes and subsequent red stain of nuclei, > 600 nm) and MDCK were further incubated for 30 min at 37°C. Before CLSM observations, cells were washed three times with serum-free medium. To determine optimal dye concentration of ethidium homodimer, cells were killed using 70% methanol for 30 min.
LDH Release
The release of LDH indicates compromised cell membrane integrity. MDCK monolayers were grown on 12-well plates and incubated with carboxyfluorescein-labeled peptides at various concentrations and times of incubation. LDH release was estimated by withdrawing a 40-l sample from each well and transferring it to 1 ml phosphate buffer (50 mM, pH 7.5) containing nicotinamide adenine dinucleotide (0.18 mM) and pyruvate (0.6 mM). The change in absorbance was measured at 340 nm using an UV spectrophotometer. Triton-X100 was used as positive control.
Investigation of hCT Receptor Expression on MDCK Cells by Measurement of cAMP Accumulation
MDCK cells were seeded onto 24-well plates at a density of 40,000 cells/well. Three days later the medium was replaced with a medium containing 136 mM NaCl, 5.4 mM KCl, 1 mM Na 2 HPO 4 , 5.5 mM glucose, 1 mM CaCl 2 , 1 mM MgCl 2 , 1 mM isobutylmethylxanthine, 0.1% bovine serum albumin, and 20 mM HEPES, pH 7.45. Incubation with test substances was performed at 37°C in a final volume of 200 l for 15 min. Thereafter, the medium was replaced by 500 l of ice-cold 95% ethanol containing 1 mM HCl, and cAMP was extracted at 4°C for 1 h. Ethanol was evaporated in a SpeedVac concentrator (Savant) and cAMP determined in reconstituted extracts by radioimmunoassay (RIA) as described by Moran et al. (27) .
RESULTS
Cellular Uptake of hCT-Derived Peptides in MDCK Cell Monolayers and Tat(47-57) and Penetratin(43-58) in both MDCK and HeLa Cells
The distributions of carboxyfluorescein and carboxyfluorescein-labeled hCT-derived peptides were followed in living, nonfixed MDCK cell monolayers grown either on cell culture inserts (transepithelial electrical resistance ‫ס‬ 111 ± 21 ⍀·cm 2 , n ‫ס‬ 68) or glass chamber slides. The localization of Tat(47-57) and penetratin(43-58) within fixed or nonfixed MDCK cell monolayers and HeLa grown on glass chamber slides was also determined. No intracellular fluorescence was observed when the cells were incubated for 45 min with the negative controls, that is, no peptide (Fig. 1A) , 40 M nonconjugated carboxyfluorescein (Fig. 1B) , or 40 M random sequence (Fig. 1C) . The latter, however, showed an extracellular fluorescence pattern. When incubated for 45 min at 37°C with MDCK cell monolayers the intracellular hCT-derived peptides (40 M) demonstrated a punctuated cytoplasmic distribution (Figs. 1D and 1E) . The translocation efficiency of peptides visually decreased in the order of hCT(9-32) ≈ hCT(12-32) > hCT(15-32) > hCT (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (Table I) . Although even the shortest fragment hCT(18-32) displayed some degree of translocation, the longest fragments such as hCT(9-32) and hCT demonstrated visually a higher degree of uptake, as assessed by the apparent fluorescence intensity of the CLSM micrographs. All internalized fragments demonstrated a sectoral distribution, as intracellular fluorescence was observed only in some regions of the monolayers and not homogeneously distributed across the cell layers (Figs. 1F and 1G). Other than fluorescence no other visually detectable differences between the cell regions with and without translocation were observed. When assayed at 4°C the hCT-derived peptides were not translocated into the cells. The fully preserved viability of the cells at 4°C was assessed with the LIVE/DEAD Viability/Cytotoxicity Assay Kit (data not shown).
To elucidate the underlying principles of the cellular uptake, the amino acid sequence of hCT(18-32) was modified as follows (for details, see Table I ). When lysine in position 18 was replaced by another basic residue, such as arginine, the capacity for translocation was conserved. Nevertheless, replacement by a non-charged amino acid, for example, alanine, or by a D-lysine abolished the uptake. Abolition of the uptake was also observed when exchanging the proline 23 with a more flexible residue, such as alanine. The extension of the sequence hCT (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) by coupling a phenylalanine to the Nterminus [N17F-hCT(17-32)], did not affect the capacity for translocation. On the other hand, when coupling a cysteine [N17C-hCT(17-32)] or a lysine [N17K-hCT (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) ] to the Nterminus and two alanines to the C-terminus [A33A34-hCT(18-34)] translocation of the peptides was abolished. The importance of the orientation for peptide internalization was demonstrated since the reverse analog hCT(32-18) was not internalized. The role of the proline at the C-terminus seemed not to be crucial since hCT (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) could permeate the plasma membrane. However, the peptide hCT(9-29) was not internalized in MDCK cells, suggesting that the C-terminal domain is essential for cellular uptake.
The metabolic breakdown of hCT in contact with cells was previously found to initiate in the mid section of the peptide, that is, close to the N-terminus of hCT (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) , predominantly through chymotryptic and tryptic-like cleavage (28) . Therefore, it was believed that replacement of L-by D-amino acid residues in the hCT fragments would enhance their metabolic stability. The impact of such amino acid modifications upon membrane translocation was also investigated.
Exchange of L-phenylalanine in position 19 and L-lysine in position 18 by their D-enantiomers abolished the membrane translocating capacity of the peptides. Confocal microscopy pictures were identical to the negative controls as shown in Figs. 1A and 1B. The hCT(9-32) and hCT fragments demonstrated similar punctuated cytoplasmic distributions whether the cells were grown on cell culture inserts or on glass chamber slides, providing evidence that the culture support had no influence on peptide uptake. Moreover, fixation of the cells before CLSM did not affect the pattern of internalization, except for a somewhat brighter fluorescence in fixed vs. nonfixed cells. Consequently, artifacts by fixation could be excluded. The fluorophore did not significantly alter peptide uptake, since hCT(9-32) fragments labeled either with carboxyfluorescein or TAMRA did not modify the cellular pattern with MDCK monolayers. These findings further support the results of Lang et al., who demonstrated that the conjugation of fluorescein isothiocyanate (FITC) to hCT had no significant influence upon the transfer of peptides across excised nasal mucosa (29) .
Concentration Effects of hCT-Derived Peptide upon Uptake into MDCK Cell Monolayers
To assess the effect of peptide concentration and to check for any saturation of the translocation, hCT(9-32), hCT and hCT (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) were incubated with MDCK cells for 45 min at 10, 20, 40, and 100 M. For CLSM inspection, cells remained nonfixed. Below the concentration of 40 M only weak intracellular fluorescence was observed. At a concentration of 40 M, detection was at optimum. At a peptide concentration of 100 M, the intracellular fluorescence did not increase, instead accumulation of apical fluorescence, presumably fluorescent aggregates of the peptides, was detected on the cell layers (Fig. 1H) . A similar aggregation pattern was also observed at 100 M with hCT-derived peptides devoid of translocating abilities.
Effect of Incubation Time upon Uptake of hCT-Derived Peptides in MDCK Cell Monolayers
hCT(9-32), hCT , and hCT (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) were also incubated at 40 M for four different times intervals: 15, 30, 45, and 60 min on MDCK cell monolayers. Negligible or poor internalization was observed at either 15 or 30 min. However, incubations for more than 30 min were sufficient for the vesicular internalization of peptides (data not shown).
Cellular Uptake of hCT-Derived Peptides in Proliferating MDCK Cells
The distribution of hCT(9-32), hCT (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) , hCT (21-32), and random sequence (40 M) was also investigated in proliferating MDCK cells after a 45-min incubation. For CLSM inspection cells were fixed. All fragments demonstrated a punctuated cytoplasmic distribution, clearly above the negative controls, that is, serum-free medium and fluorophore, respectively. The punctuated cytoplasmic distribution of hCT (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) is illustrated in Fig. 1 (data not shown for hCT , hCT (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) , and random sequence). When hCT(9-32) was concomitantly incubated with TRITC-dextran (Fig. 1J) , it was found to predominantly co-localize with TRITC-dextran (Fig. 1K) , as indicated by the resulting yellow coloration (Fig.   1L ), demonstrating the endocytotic nature of the cellular uptake of hCT-derived peptides. At the same time, the discrete observation of green and red vesicles indicated independent uptake of the peptide and the fluid phase endocytic marker (Fig. 1L) . No uptake of TRITC-dextran was observed in confluent MDCK cells.
Cellular Uptake of Tat(47-57) and Penetratin(43-58) in MDCK Cell Monolayers and HeLa Cells
The highly positively charged carrier peptides Tat(47-57) and penetratin(43-58) were also incubated with MDCK monolayers for 1 h with a concentration of 10 M. Tat(47-57) demonstrated a cytoplasmic and punctuated pattern in fixed cells. Although analogous to that observed with the hCTderived peptides, the pattern was more uniformly distributed across the monolayers with Tat(47-57) ( Figs. 2A and 2B ). With penetratin(43-58), however, concomitant staining of the surface of the plasma membrane and intracellular translocation was observed (Figs. 2C and 2D ). When using nonfixed MDCK cell monolayers, the intracellular patterns of the two cationic CPP were weaker but still punctuated and cytoplasmic. In living nonfixed and fixed HeLa cells, Tat(47-57) and penetratin(43-58) (10 M) were mainly located in the cytoplasm with a punctuated distribution after 1 h of incubation (Figs. 2E and 2F) .
Cytotoxicity of hCT(9-32), hCT(18-32), hCT(21-32), Tat(47-57), and Penetratin(43-58) on MDCK Cell Monolayers
hCT-derived peptides were incubated at 40 M for three different incubation times: 30, 60, and 120 min (n ‫ס‬ 4; Fig.  3A ). Tat(47-57) and penetratin(43-58) peptides were incubated at a concentration of 10 M during 60, 120, 180, and 240 min (n ‫ס‬ 4; Fig. 3B ). Triton X-100 (0.1% in serum-free medium) was used as positive control and serum-free medium as negative one. The results are represented as percentage of LDH release. The percentages were calculated by direct comparison to the positive control, that is, when the cell membranes were permeabilized by Triton X-100. The LDH release of the positive control was taken as 100%. As depicted in Figs. 3A and 3B, no significant differences in the percentage of LDH release were measured when the cells were incubated with serum-free medium alone or with peptide solutions. Therefore, none of the peptides tested in this study showed a relevant toxic effect on the MDCK cell monolayers, even after 4 h of incubation with Tat(47-57) and penetratin(43-58), at the indicated concentrations.
Assessment of hCT Receptor Expression on MDCK Cells
hCT, hCGRP, hADM, and hAmylin belong to a family of structurally and functionally related peptides that recognize their respective receptors with affinity in the nanomolar range (30) , resulting in accumulation of cAMP. However, cross-reactivity of a given receptor with other peptides of the family is observed at high concentrations (micromolar range). We incubated MDCK cells with hCT, hCGRP, hADM, and hAmylin to verify whether the cells possess any calcitonin receptor activity and, if any, cross-reactivity was present. Forskolin, which stimulates adenylate cyclase, was used as a positive control to verify the capacity to produce cAMP. No sig- nificant accumulation of cAMP in response to hCT, hCGRP, hADM and hAmylin, was monitored (Fig. 4) , cAMP levels remained in the range of untreated controls (2-7 pmol/well). MDCK appeared not to possess any calcitonin or calcitonin related receptor activity, thus suggesting that hCT-derived peptides use an alternative mechanism to translocate into MDCK.
DISCUSSION
Numerous peptide sequences derived from proteins with membrane translocating properties were previously investigated for their capacity as carrier peptides for the transfer of various cargoes into the cytosol of a variety of cells (4, 5, 31) . Many of these CPP are highly positively charged and strongly interact with the negatively charged extracellular matrix of the plasma membrane (3, 32) . In the present study, we investigated the cell-penetrating capacities of peptides carrying relatively modest net positive charges or being neutral, namely C-terminal fragments of hCT, into a columnar-type epithelium, the MDCK monolayer using CLSM. hCT was previously shown to translocate the plasma membrane of excised bovine nasal mucosa (22) , and to act as a transfer vehicle for GFP into this tissue model (23) . Prerequisite for assessing the capability of hCT-derived peptides to pass the plasma membrane of MDCK is direct detection and sufficient resolution by CLSM. However, several aspects need to be considered to interpret such observations. In principle, the observed intracellular fluorescence may be emitted by either intact peptides or metabolites still carrying the fluorophore.
For this study, we synthesized 20 different C-terminal sequences derived from hCT (see Table I ). Seven of them translocated the plasma membrane of confluent MDCK monolayers. The shortest internalized hCT-derived peptide sequence was hCT (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) . Shorter sequences lacked relevant translocating capacity, whereas longer fragments in fact permeated the cell membrane. The efficiency of translocation visually decreased in the order of hCT(9-32) ≈ hCT(12-32) > hCT(15-32) > hCT (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) . We also looked at the important structural features required for internalization by modifications of the original amino acid sequence. Among these, we tried to increase the helicity of the peptide sequence in replacing the proline 23 by an alanine. This modification in fact abolished the internalization of the peptide and highlights the importance of the proline in this position. Among other reasons, the rigidity induced by the proline could be crucial for efficient peptide internalization. By replacing the lysine in position 18, we addressed the involvement of ionic interactions and the contribution of the positive charge on membrane translocation. The impact of a single positive net charge is expected to be much inferior to that of multiple positive charges as typically found in polycationic carrier peptides, for example, Tat(47-57). Polycationic CPPs have been previously reported to strongly interact with the extracellular matrix of plasma membranes (6, 33) . Nevertheless, there could be a contribution of the positive charge of the lysine in position 18 in anchoring the sequences at the bilayer surface. Replacement of lysine by noncharged alanine prevented peptide internalization, whereas maintaining the positive charge by replacing the lysine with an arginine maintained peptide internalization. However, the conformation of the positive charge at this position seemed to play a crucial role, since the replacement of L-lysine by D-lysine strikingly abolished uptake. Another role of the lysine in position 18 might be the inhibition of premature aggregation through charge repulsion. If not stabilized by a minimum positive charge hydrophobic interactions of the C-terminal domain could prevail and lead to premature aggregation, that is, inactivation of shorter hCT fragments than hCT (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) . Nevertheless, this would not explain the failure of D-lysine replacement.
Sequence extension of hCT (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) beyond the N-and C-termini showed in most of the cases a loss of internalization except when phenylalanine was added to the N-terminus. Therefore, introduction of a peptidic spacer to serve as a cargolinker, should be engineered at the N-terminus, possibly by adding a phenylalanine.
In most of the previous studies, cells incubated with polycationic CPP, demonstrated rapid peptide uptake with predominant nuclear localization and lack of punctuated cytoplasmic labeling, which is characteristic of endocytic uptake. Additionally, internalization of CPP was not significantly inhibited at low temperature, and structure-activity studies often suggested that internalization did not depend on the secondary structure, ruling out putative receptor recognition. It was thus commonly accepted that the internalization of CPPs would not involve endocytosis or specific protein transporters. Instead, passive transfer through the lipid bilayer has been proposed as a possible mechanism of translocation (3, 6, 9, 10, 16) . Recent studies, however, contrast with this hypothesis, after a punctuated cytoplasmic distribution of Tat(48-60) and poly-arginine in HeLa and CHO cells was observed (18) . Koppelhus et al. showed that a PNA conjugated to C-Tat(48-60) or a modified penetratin(42-58) was found to predominantly segregate in endocytic vesicles (17) . Both of them described an energy-dependent uptake mechanism.
In the present study, we demonstrated a sectoral, punctuated cytoplasmic localization of translocated hCT-derived peptides and the absence of any nuclear fluorescence. This latter fact may be explained by the absence of a nuclear translocating motif in the sequence of the investigated peptides. Yet, without further knowledge, explanation for the observed sectoral distribution is still elusive. In addition, our study suggested an energy-, time-and concentration-dependent mechanism. However, at concentrations above 100 M the hydrophobic C-termini of the hCT-derived peptides appear to strongly interact and lead to the formation of aggregates as thoroughly studied for hCT itself (34) . Premature aggregation of a peptide would efficiently prevent its internalization in a non-concentration-dependent manner. The absence of significant translocation of distinct modifications, particularly of hCT , D-K18-hCT (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) and D-F19-hCT (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) , vs. translocation of others, does not exclude the involvement of a receptor-dependent mechanism. However, owing to the demonstrated absence of hCT and hCT-related receptors on MDCK plasma membranes, the involvement of this receptor must be excluded. Nevertheless, an alternative receptor to the calcitonin receptor might assist in peptide internalization.
For comparison, Tat(47-57) showed a punctuated cytoplasmic pattern, indicating endocytic vesicles, whereas penetratin(43-58) depicted both a cytoplasmic and punctuated pattern, and an extracellular staining of the cell membrane. However, when incubated with HeLa cells, both Tat(47-57) and penetratin(43-58) demonstrated a similar punctuated cytoplasmic pattern. In MDCK and HeLa cells both peptides demonstrated only weak nuclear uptake. Contrasting to the present results, two independent studies recently claimed that Tat(48-57) and Tat(44-57) cannot permeate MDCK plasma membrane (35, 36) . Nevertheless, distinct differences in both the Tat sequences, the cell culture and other experimental protocols limit the possibilities to interpret this discrepancy here.
Our data strongly support the involvement of endocytosis as the major route for the internalization of hCT-derived peptides, Tat(47-57) and penetratin(43-58) into MDCK monolayers, in contrast to the direct cytosolic pathway suggested for other peptides (3,6,10). However, it is important to note The release of LDH is depicted relative to the release amount of LDH from epithelium exposed to 0.1% Triton X-100. No relevant toxicity is observed. Mean ± SD (n ‫ס‬ 4). that the efficiency of peptide uptake was dependent upon both cell line and peptide sequence. HeLa cells demonstrated a greater uptake potential than MDCK cells, and Tat(47-57) was more readily internalized as compared to the hCT-derived peptides. These results indicate that the uptake probably depends on a cell-specific membrane component or the specific lipid composition of the membrane. The endocytic pathway can expose peptide, protein and nucleic acid basedtherapeutics to late endosomal and lysosomal degradation and, therefore, may represent a problematic pathway for drug delivery. A recent study showed that when fused to Tat(47-57), lysosomal ␤-glucuronidase was internalized by endocytosis and the fusion protein's enzyme activity restored in a mouse model of ␤-glucuronidase deficiency (37) . This demonstrates that a translocated cargo may retain its biological activity even when transported via an endocytic pathway. Alternatively, endosomal/lysosomal degradation could be considered as an attractive feature to release the therapeutic principle from its conjugate. This would necessitate the existence of a suitable metabolically cleavable spacer between cargo and peptide.
Recently, artifactual uptake of some CPPs was demonstrated upon strong and even mild fixation conditions (18, 38) . In our study, under both fixed and nonfixed conditions, HeLa cells showed a similar fluorescence pattern, indicating the absence of experimental artifacts upon fixation. Supporting this view is the recent study of Koppelhus et al. demonstrating that fixation did not negatively effect the vesicular translocation pattern of PNA conjugated to CPPs (17) . Nevertheless, nonfixed MDCK cells demonstrated a somewhat weaker but otherwise identical, punctuated cytoplasmic fluorescence (not shown). This result is explained by a higher bleaching of carboxyfluorescein in nonfixed cells vs. fixed cells (39) . In case of artifactual redistribution of the peptides after fixation, a predominantly nuclear localization and the lack of punctuated cytoplasmic labeling characteristics of endocytic uptake would be expected, as reported in most published data on fixed cells (3, 10, 16) .
Interestingly, we found an nonspecific uptake of all the tested hCT-derived sequences by proliferating MDCK cells, whereas selected peptides only were internalized by confluent MDCK. PNA-peptide conjugates also demonstrate faster cellular uptake when using less confluent cells, demonstrating an influence of the physiologic state of the cells relative to peptide uptake (17) . Our findings may point to a more complex and less general mechanism for the uptake of hCT-derived peptides in MDCK monolayers as compared to proliferating cells.
The release of cytoplasmic LDH into the cell culture supernatant was studied to assess plasma membrane damage when MDCK cell monolayers were incubated with hCT-derived peptides, Tat(47-57) and penetratin(43-58). No significant toxicity induced by the tested peptides was detected. Koppelhus et al. described a diffuse, strong staining of both the cytoplasm and the nuclei when the peptides were toxic (17) . The well-defined, punctuated cytoplasmic pattern, described in the present work, provides further support in demonstrating that the peptide sequences used in this study did no exert significant toxicity when incubated with either MDCK or HeLa.
In conclusion, we propose a new family of modestly cationic peptides, all derived from human calcitonin, that are able to translocate MDCK plasma membrane. The translocated hCT peptides demonstrated a sectoral and punctuated cytoplasmic distribution. Polycationic CPP such as Tat(47-57) and penetratin(43-58) also showed a punctuated cytoplasmic distribution in MDCK and HeLa cells. The results obtained in our study in combination with those of other laboratories lend support to endocytosis as the common mechanism for peptide translocation. At this point, it is difficult to outline the structural requirements for efficient internalization of hCT-derived peptides. Moreover, the observed structure-activity relationship of studied peptides may also relate to variations in their aggregation potential, as well as differences in their pathway and rate of metabolism. Work is undergoing to assess the different metabolism kinetics of selected hCT-derived peptides and to optimize the translocating abilities of hCT-derived peptides. Therefore, further studies need to be performed to identify an optimized sequence for translocation and mechanism of action of our CPP.
